Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes

Mark E. Molitch; Amanda I. Adler; Allan Flyvbjerg; Robert G. Nelson; Wing Yee So; Christoph Wanner; Bertram L. Kasiske; David C. Wheeler; Dick De Zeeuw; Carl E. Mogensen

doi:10.1038/ki.2014.128

Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes

Mark E. Molitch^*, Amanda I. Adler, Allan Flyvbjerg, Robert G. Nelson, Wing Yee So, Christoph Wanner, Bertram L. Kasiske, David C. Wheeler, Dick De Zeeuw, Carl E. Mogensen

^*Corresponding author for this work

Medicine, Endocrinology Division

Research output: Contribution to journal › Article › peer-review

185 Scopus citations

Abstract

The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout The world, due primarily to The increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced The proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), The sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in The management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of The renin-angiotensin-aldosterone system; and lipid management.

Original language	English (US)
Pages (from-to)	20-30
Number of pages	11
Journal	Kidney international
Volume	87
Issue number	1
DOIs	https://doi.org/10.1038/ki.2014.128
State	Published - Jan 3 2015

Keywords

Albuminuria
blood pressure
diabetic kidney disease
glycemic control
lipid management

ASJC Scopus subject areas

Nephrology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/ki.2014.128

Cite this

@article{08ca89d53f65453e8cde2ed31f816f83,

title = "Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes",

abstract = "The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout The world, due primarily to The increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced The proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), The sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in The management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of The renin-angiotensin-aldosterone system; and lipid management.",

keywords = "Albuminuria, blood pressure, diabetic kidney disease, glycemic control, lipid management",

author = "Molitch, {Mark E.} and Adler, {Amanda I.} and Allan Flyvbjerg and Nelson, {Robert G.} and So, {Wing Yee} and Christoph Wanner and Kasiske, {Bertram L.} and Wheeler, {David C.} and {De Zeeuw}, Dick and Mogensen, {Carl E.}",

note = "Funding Information: This conference was sponsored by KDIGO with support from Biocon. This work was also supported in part by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases. Publisher Copyright: {\textcopyright} 2015 International Society of Nephrology.",

year = "2015",

month = jan,

day = "3",

doi = "10.1038/ki.2014.128",

language = "English (US)",

volume = "87",

pages = "20--30",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Diabetic kidney disease

T2 - A clinical update from Kidney Disease: Improving Global Outcomes

AU - Molitch, Mark E.

AU - Adler, Amanda I.

AU - Flyvbjerg, Allan

AU - Nelson, Robert G.

AU - So, Wing Yee

AU - Wanner, Christoph

AU - Kasiske, Bertram L.

AU - Wheeler, David C.

AU - De Zeeuw, Dick

AU - Mogensen, Carl E.

N1 - Funding Information: This conference was sponsored by KDIGO with support from Biocon. This work was also supported in part by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases. Publisher Copyright: © 2015 International Society of Nephrology.

PY - 2015/1/3

Y1 - 2015/1/3

N2 - The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout The world, due primarily to The increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced The proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), The sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in The management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of The renin-angiotensin-aldosterone system; and lipid management.

AB - The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout The world, due primarily to The increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced The proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), The sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in The management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of The renin-angiotensin-aldosterone system; and lipid management.

KW - Albuminuria

KW - blood pressure

KW - diabetic kidney disease

KW - glycemic control

KW - lipid management

UR - http://www.scopus.com/inward/record.url?scp=84920272288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920272288&partnerID=8YFLogxK

U2 - 10.1038/ki.2014.128

DO - 10.1038/ki.2014.128

M3 - Article

C2 - 24786708

AN - SCOPUS:84920272288

SN - 0085-2538

VL - 87

SP - 20

EP - 30

JO - Kidney International

JF - Kidney International

IS - 1

ER -

Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this